There were 867 press releases posted in the last 24 hours and 166,824 in the last 365 days.

Global Chronic Obstructive Pulmonary Disease Industry

Chronic Obstructive Pulmonary Disease market worldwide is projected to grow by US$6 Billion, driven by a compounded growth of 4. 7%. Bronchodilators, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Chronic Obstructive Pulmonary Disease Industry" - https://www.reportlinker.com/p05817979/?utm_source=GNW
1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$5.8 Billion by the year 2025, Bronchodilators will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 3.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$212.2 Million to the region’s size and clout in the next 5 to 6 years. Over US$174.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Bronchodilators will reach a market size of US$255.8 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.4% over the next couple of years and add approximately US$1.7 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, AstraZeneca PLC; Boehringer Ingelheim GmbH; Chiesi Farmaceutici SpA; GlaxoSmithKline PLC; Mylan NV; Novartis International AG; Orion Corporation; Sunovion Pharmaceuticals, Inc.; Teva Pharmaceutical Industries Ltd.


Read the full report: https://www.reportlinker.com/p05817979/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Chronic Obstructive Pulmonary Disease Competitor Market Share
Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Chronic Obstructive Pulmonary Disease Global Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 2: Chronic Obstructive Pulmonary Disease Global
Retrospective Market Scenario in US$ Million by Region/Country:
2009-2017
Table 3: Chronic Obstructive Pulmonary Disease Market Share
Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Bronchodilators (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Bronchodilators (Drug Class) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 6: Bronchodilators (Drug Class) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Combination (Drug Class) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Combination (Drug Class) Historic Market Perspective
by Region/Country in US$ Million: 2009 to 2017
Table 9: Combination (Drug Class) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Phosphodiesterase Type 4 Inhibitors (Drug Class)
Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Phosphodiesterase Type 4 Inhibitors (Drug Class)
Region Wise Breakdown of Global Historic Demand in US$ Million:
2009 to 2017
Table 12: Phosphodiesterase Type 4 Inhibitors (Drug Class)
Market Share Distribution in Percentage by Region/Country: 2009
VS 2019 VS 2025
Table 13: Mucokinetics (Drug Class) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Mucokinetics (Drug Class) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Mucokinetics (Drug Class) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Corticosteroids (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Corticosteroids (Drug Class) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 18: Corticosteroids (Drug Class) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 19: Other Drug Class (Drug Class) World Market Estimates
and Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Other Drug Class (Drug Class) Market Worldwide
Historic Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Other Drug Class (Drug Class) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Chronic Obstructive Pulmonary Disease Market Share (in %) by
Company: 2019 & 2025
Table 22: United States Chronic Obstructive Pulmonary Disease
Market Estimates and Projections in US$ Million by Drug Class:
2018 to 2025
Table 23: Chronic Obstructive Pulmonary Disease Market in the
United States by Drug Class: A Historic Review in US$ Million
for 2009-2017
Table 24: United States Chronic Obstructive Pulmonary Disease
Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
CANADA
Table 25: Canadian Chronic Obstructive Pulmonary Disease Market
Estimates and Forecasts in US$ Million by Drug Class: 2018 to
2025
Table 26: Canadian Chronic Obstructive Pulmonary Disease
Historic Market Review by Drug Class in US$ Million: 2009-2017
Table 27: Chronic Obstructive Pulmonary Disease Market in
Canada: Percentage Share Breakdown of Sales by Drug Class for
2009, 2019, and 2025
JAPAN
Table 28: Japanese Market for Chronic Obstructive Pulmonary
Disease: Annual Sales Estimates and Projections in US$ Million
by Drug Class for the Period 2018-2025
Table 29: Chronic Obstructive Pulmonary Disease Market in
Japan: Historic Sales Analysis in US$ Million by Drug Class for
the Period 2009-2017
Table 30: Japanese Chronic Obstructive Pulmonary Disease Market
Share Analysis by Drug Class: 2009 VS 2019 VS 2025
CHINA
Table 31: Chinese Chronic Obstructive Pulmonary Disease Market
Growth Prospects in US$ Million by Drug Class for the Period
2018-2025
Table 32: Chronic Obstructive Pulmonary Disease Historic Market
Analysis in China in US$ Million by Drug Class: 2009-2017
Table 33: Chinese Chronic Obstructive Pulmonary Disease Market
by Drug Class: Percentage Breakdown of Sales for 2009, 2019,
and 2025
EUROPE
Market Facts & Figures
European Chronic Obstructive Pulmonary Disease Market:
Competitor Market Share Scenario (in %) for 2019 & 2025
Table 34: European Chronic Obstructive Pulmonary Disease Market
Demand Scenario in US$ Million by Region/Country: 2018-2025
Table 35: Chronic Obstructive Pulmonary Disease Market in
Europe: A Historic Market Perspective in US$ Million by
Region/Country for the Period 2009-2017
Table 36: European Chronic Obstructive Pulmonary Disease Market
Share Shift by Region/Country: 2009 VS 2019 VS 2025
Table 37: European Chronic Obstructive Pulmonary Disease Market
Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Table 38: Chronic Obstructive Pulmonary Disease Market in
Europe in US$ Million by Drug Class: A Historic Review for the
Period 2009-2017
Table 39: European Chronic Obstructive Pulmonary Disease Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
FRANCE
Table 40: Chronic Obstructive Pulmonary Disease Market in
France by Drug Class: Estimates and Projections in US$ Million
for the Period 2018-2025
Table 41: French Chronic Obstructive Pulmonary Disease Historic
Market Scenario in US$ Million by Drug Class: 2009-2017
Table 42: French Chronic Obstructive Pulmonary Disease Market
Share Analysis by Drug Class: 2009 VS 2019 VS 2025
GERMANY
Table 43: Chronic Obstructive Pulmonary Disease Market in
Germany: Recent Past, Current and Future Analysis in US$
Million by Drug Class for the Period 2018-2025
Table 44: German Chronic Obstructive Pulmonary Disease Historic
Market Analysis in US$ Million by Drug Class: 2009-2017
Table 45: German Chronic Obstructive Pulmonary Disease Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
ITALY
Table 46: Italian Chronic Obstructive Pulmonary Disease Market
Growth Prospects in US$ Million by Drug Class for the Period
2018-2025
Table 47: Chronic Obstructive Pulmonary Disease Historic Market
Analysis in Italy in US$ Million by Drug Class: 2009-2017
Table 48: Italian Chronic Obstructive Pulmonary Disease Market
by Drug Class: Percentage Breakdown of Sales for 2009, 2019,
and 2025
UNITED KINGDOM
Table 49: United Kingdom Market for Chronic Obstructive
Pulmonary Disease: Annual Sales Estimates and Projections in
US$ Million by Drug Class for the Period 2018-2025
Table 50: Chronic Obstructive Pulmonary Disease Market in the
United Kingdom: Historic Sales Analysis in US$ Million by Drug
Class for the Period 2009-2017
Table 51: United Kingdom Chronic Obstructive Pulmonary Disease
Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
SPAIN
Table 52: Spanish Chronic Obstructive Pulmonary Disease Market
Estimates and Forecasts in US$ Million by Drug Class: 2018 to
2025
Table 53: Spanish Chronic Obstructive Pulmonary Disease
Historic Market Review by Drug Class in US$ Million: 2009-2017
Table 54: Chronic Obstructive Pulmonary Disease Market in
Spain: Percentage Share Breakdown of Sales by Drug Class for
2009, 2019, and 2025
RUSSIA
Table 55: Russian Chronic Obstructive Pulmonary Disease Market
Estimates and Projections in US$ Million by Drug Class: 2018 to
2025
Table 56: Chronic Obstructive Pulmonary Disease Market in
Russia by Drug Class: A Historic Review in US$ Million for
2009-2017
Table 57: Russian Chronic Obstructive Pulmonary Disease Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 58: Rest of Europe Chronic Obstructive Pulmonary Disease
Market Estimates and Forecasts in US$ Million by Drug Class:
2018-2025
Table 59: Chronic Obstructive Pulmonary Disease Market in Rest
of Europe in US$ Million by Drug Class: A Historic Review for
the Period 2009-2017
Table 60: Rest of Europe Chronic Obstructive Pulmonary Disease
Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 61: Asia-Pacific Chronic Obstructive Pulmonary Disease
Market Estimates and Forecasts in US$ Million by
Region/Country: 2018-2025
Table 62: Chronic Obstructive Pulmonary Disease Market in
Asia-Pacific: Historic Market Analysis in US$ Million by
Region/Country for the Period 2009-2017
Table 63: Asia-Pacific Chronic Obstructive Pulmonary Disease
Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 64: Chronic Obstructive Pulmonary Disease Market in
Asia-Pacific by Drug Class: Estimates and Projections in US$
Million for the Period 2018-2025
Table 65: Asia-Pacific Chronic Obstructive Pulmonary Disease
Historic Market Scenario in US$ Million by Drug Class:
2009-2017
Table 66: Asia-Pacific Chronic Obstructive Pulmonary Disease
Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
AUSTRALIA
Table 67: Chronic Obstructive Pulmonary Disease Market in
Australia: Recent Past, Current and Future Analysis in US$
Million by Drug Class for the Period 2018-2025
Table 68: Australian Chronic Obstructive Pulmonary Disease
Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 69: Australian Chronic Obstructive Pulmonary Disease
Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
INDIA
Table 70: Indian Chronic Obstructive Pulmonary Disease Market
Estimates and Forecasts in US$ Million by Drug Class: 2018 to
2025
Table 71: Indian Chronic Obstructive Pulmonary Disease Historic
Market Review by Drug Class in US$ Million: 2009-2017
Table 72: Chronic Obstructive Pulmonary Disease Market in
India: Percentage Share Breakdown of Sales by Drug Class for
2009, 2019, and 2025
SOUTH KOREA
Table 73: Chronic Obstructive Pulmonary Disease Market in South
Korea: Recent Past, Current and Future Analysis in US$ Million
by Drug Class for the Period 2018-2025
Table 74: South Korean Chronic Obstructive Pulmonary Disease
Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 75: Chronic Obstructive Pulmonary Disease Market Share
Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 76: Rest of Asia-Pacific Market for Chronic Obstructive
Pulmonary Disease: Annual Sales Estimates and Projections in
US$ Million by Drug Class for the Period 2018-2025
Table 77: Chronic Obstructive Pulmonary Disease Market in Rest
of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug
Class for the Period 2009-2017
Table 78: Rest of Asia-Pacific Chronic Obstructive Pulmonary
Disease Market Share Analysis by Drug Class: 2009 VS 2019 VS
2025
LATIN AMERICA
Table 79: Latin American Chronic Obstructive Pulmonary Disease
Market Trends by Region/Country in US$ Million: 2018-2025
Table 80: Chronic Obstructive Pulmonary Disease Market in Latin
America in US$ Million by Region/Country: A Historic
Perspective for the Period 2009-2017
Table 81: Latin American Chronic Obstructive Pulmonary Disease
Market Percentage Breakdown of Sales by Region/Country: 2009,
2019, and 2025
Table 82: Latin American Chronic Obstructive Pulmonary Disease
Market Growth Prospects in US$ Million by Drug Class for the
Period 2018-2025
Table 83: Chronic Obstructive Pulmonary Disease Historic Market
Analysis in Latin America in US$ Million by Drug Class:
2009-2017
Table 84: Latin American Chronic Obstructive Pulmonary Disease
Market by Drug Class: Percentage Breakdown of Sales for 2009,
2019, and 2025
ARGENTINA
Table 85: Argentinean Chronic Obstructive Pulmonary Disease
Market Estimates and Forecasts in US$ Million by Drug Class:
2018-2025
Table 86: Chronic Obstructive Pulmonary Disease Market in
Argentina in US$ Million by Drug Class: A Historic Review for
the Period 2009-2017
Table 87: Argentinean Chronic Obstructive Pulmonary Disease
Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
BRAZIL
Table 88: Chronic Obstructive Pulmonary Disease Market in
Brazil by Drug Class: Estimates and Projections in US$ Million
for the Period 2018-2025
Table 89: Brazilian Chronic Obstructive Pulmonary Disease
Historic Market Scenario in US$ Million by Drug Class:
2009-2017
Table 90: Brazilian Chronic Obstructive Pulmonary Disease
Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
MEXICO
Table 91: Chronic Obstructive Pulmonary Disease Market in
Mexico: Recent Past, Current and Future Analysis in US$ Million
by Drug Class for the Period 2018-2025
Table 92: Mexican Chronic Obstructive Pulmonary Disease
Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 93: Mexican Chronic Obstructive Pulmonary Disease Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 94: Rest of Latin America Chronic Obstructive Pulmonary
Disease Market Estimates and Projections in US$ Million by Drug
Class: 2018 to 2025
Table 95: Chronic Obstructive Pulmonary Disease Market in Rest
of Latin America by Drug Class: A Historic Review in US$
Million for 2009-2017
Table 96: Rest of Latin America Chronic Obstructive Pulmonary
Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS
2025
MIDDLE EAST
Table 97: The Middle East Chronic Obstructive Pulmonary Disease
Market Estimates and Forecasts in US$ Million by
Region/Country: 2018-2025
Table 98: Chronic Obstructive Pulmonary Disease Market in the
Middle East by Region/Country in US$ Million: 2009-2017
Table 99: The Middle East Chronic Obstructive Pulmonary Disease
Market Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 100: The Middle East Chronic Obstructive Pulmonary
Disease Market Estimates and Forecasts in US$ Million by Drug
Class: 2018 to 2025
Table 101: The Middle East Chronic Obstructive Pulmonary
Disease Historic Market by Drug Class in US$ Million:
2009-2017
Table 102: Chronic Obstructive Pulmonary Disease Market in the
Middle East: Percentage Share Breakdown of Sales by Drug Class
for 2009, 2019, and 2025
IRAN
Table 103: Iranian Market for Chronic Obstructive Pulmonary
Disease: Annual Sales Estimates and Projections in US$ Million
by Drug Class for the Period 2018-2025
Table 104: Chronic Obstructive Pulmonary Disease Market in
Iran: Historic Sales Analysis in US$ Million by Drug Class for
the Period 2009-2017
Table 105: Iranian Chronic Obstructive Pulmonary Disease Market
Share Analysis by Drug Class: 2009 VS 2019 VS 2025
ISRAEL
Table 106: Israeli Chronic Obstructive Pulmonary Disease Market
Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Table 107: Chronic Obstructive Pulmonary Disease Market in
Israel in US$ Million by Drug Class: A Historic Review for the
Period 2009-2017
Table 108: Israeli Chronic Obstructive Pulmonary Disease Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 109: Saudi Arabian Chronic Obstructive Pulmonary Disease
Market Growth Prospects in US$ Million by Drug Class for the
Period 2018-2025
Table 110: Chronic Obstructive Pulmonary Disease Historic
Market Analysis in Saudi Arabia in US$ Million by Drug Class:
2009-2017
Table 111: Saudi Arabian Chronic Obstructive Pulmonary Disease
Market by Drug Class: Percentage Breakdown of Sales for 2009,
2019, and 2025
UNITED ARAB EMIRATES
Table 112: Chronic Obstructive Pulmonary Disease Market in the
United Arab Emirates: Recent Past, Current and Future Analysis
in US$ Million by Drug Class for the Period 2018-2025
Table 113: United Arab Emirates Chronic Obstructive Pulmonary
Disease Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 114: Chronic Obstructive Pulmonary Disease Market Share
Distribution in United Arab Emirates by Drug Class: 2009 VS
2019 VS 2025
REST OF MIDDLE EAST
Table 115: Chronic Obstructive Pulmonary Disease Market in Rest
of Middle East: Recent Past, Current and Future Analysis in US$
Million by Drug Class for the Period 2018-2025
Table 116: Rest of Middle East Chronic Obstructive Pulmonary
Disease Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 117: Rest of Middle East Chronic Obstructive Pulmonary
Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS
2025
AFRICA
Table 118: African Chronic Obstructive Pulmonary Disease Market
Estimates and Projections in US$ Million by Drug Class: 2018 to
2025
Table 119: Chronic Obstructive Pulmonary Disease Market in
Africa by Drug Class: A Historic Review in US$ Million for
2009-2017
Table 120: African Chronic Obstructive Pulmonary Disease Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

ASTRAZENECA PLC
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CHIESI FARMACEUTICI SPA
GLAXOSMITHKLINE PLC
MYLAN NV
NOVARTIS INTERNATIONAL AG
ORION CORPORATION
SUNOVION PHARMACEUTICALS
TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817979/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.